Fulflex Acquires 300,000-Square-Foot Texas Medical Manufacturing Facility to Expand U.S. Healthcare Platform
Fulflex Acquires 300,000-Square-Foot, Fully Automated Medical Products Manufacturing Facility In Texas
Fulflex has completed the acquisition of a 300,000-square-foot medical products manufacturing facility in Jacksonville, Texas, significantly expanding its North American production capacity and reinforcing its strategy to build a larger global healthcare manufacturing platform.
Located on a 30-acre campus, the facility becomes one of Fulflex’s largest and most advanced manufacturing sites worldwide. The acquisition also brings more than 250 employees into the company, strengthening its manufacturing workforce while establishing a larger operational presence in East Texas.
The Jacksonville facility produces a broad range of medical products used by healthcare providers and patients globally. Its manufacturing capabilities include plastics injection molding, blow molding, thermoforming, extrusion, automated assembly and other advanced production technologies, enabling Fulflex to increase output while supporting customers with scalable, high-quality manufacturing solutions.
“This is an exciting day for Fulflex and for the Jacksonville community,” said Diya Garware Ibanez, Chairperson of Fulflex. “We are delighted to officially welcome the Jacksonville team into the Fulflex family. This acquisition reflects our confidence in the exceptional people, the advanced manufacturing capabilities of this facility, and the long-term future of healthcare manufacturing in East Texas. We are committed to investing in this facility, creating new opportunities for our employees, supporting our customers with world-class manufacturing, and contributing positively to the Jacksonville community for many years to come.”
The acquisition expands Fulflex’s manufacturing footprint across North America while increasing capacity in polymer processing, medical device manufacturing and automated production. The additional facility also enhances supply chain resilience by providing greater geographic diversification and production flexibility for customers operating in global healthcare markets.
The investment aligns with Fulflex’s long-term strategy of expanding through advanced manufacturing assets that strengthen operational scale and support growing demand for medical products. The company said it plans to build on the Jacksonville facility’s existing capabilities through continued investments in manufacturing technology, quality systems, operational excellence and workforce development.
“Every acquisition begins and ends with people,” Garware Ibanez said. “The dedication, experience, and commitment of the Jacksonville employees are the foundation of this facility’s success. We are honored that so many talented people have chosen to continue this journey with us, and we look forward to building an organization where our employees can grow, our customers can succeed, and our community can thrive.”
The transition was formally marked with a community event attended by employees, customers, local officials and business leaders, underscoring the company’s commitment to maintaining the facility’s operations while investing in its long-term growth.
Following the acquisition, Fulflex operates 14 locations worldwide, including four manufacturing facilities in the United States, one manufacturing facility in the Dominican Republic, two manufacturing facilities in India, and seven sales offices and distribution centers across eight countries. The company’s global network serves customers in more than 85 countries, providing medical products and engineered polymer solutions for applications spanning medical devices, patient care, rehabilitation and personal protective equipment.
By expanding its U.S. manufacturing base with one of its largest production facilities, Fulflex is positioning itself to support increasing demand from healthcare customers while strengthening its role as a global contract manufacturing partner with enhanced capacity, operational flexibility and regional supply chain capabilities.
